Delivery Order SPE2DB20D2104-SPE2DB22FS77M
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The $1,937.68 firm fixed-price contract has an ultimate completion date of August 3, 2021. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The $1,642.50 firm fixed-price contract has an ultimate completion date of August 11, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The $3,133.80 firm-fixed-price contract has a completion date of December 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FF6R5) valued at $1,618.14 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract was awarded on May 18, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a completion date of May 19, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/ml 3ml insulin pens. The $1,105.74 firm fixed-price contract has a completion date of November 13, 2023 and is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The contract has a total ceiling value of $1,294.95 and a performance period through May 16, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,129.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens, with a completion date of February 26, 2024. This delivery order is issued under a larger, single award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The $2,106.08 firm-fixed-price contract has an ultimate completion date of April 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,455.03 for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML insulin delivery pens. The award was made by the Defense Logistics Agency (DLA), a major component of the Department of Defense responsible for providing medical products and supplies to military healthcare programs. The contract has a completion date of November 9, 2022 and is a Firm Fixed Price arrangement. No...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The $4,750.40 firm fixed-price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies to support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS77MDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The $1,767.72 firm fixed-price contract has a completion date of May 19, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was competitively awarded. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential medications and medical commodities to federal healthcare agencies, including the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 5/18/22 |